Proteomics

Dataset Information

0

Mapping and Quantification of Brain Protein O-GlcNAcylation in Alzheimer’s Disease


ABSTRACT: Comprehensive, quantitative proteomics analysis of protein O-GlcNAcylation in post-mortem human brains with and without Alzheimer’s using isobaric tandem mass tags labeling, chemoenzymatic photocleavage enrichment and liquid chromatography coupled to mass spectrometry.

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cerebral Gray Matter

DISEASE(S): Alzheimer's Disease

SUBMITTER: Matthew Monroe  

LAB HEAD: Tao Liu

PROVIDER: PXD004510 | Pride | 2017-09-04

REPOSITORIES: pride

altmetric image

Publications

Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease.

Wang Sheng S   Yang Feng F   Petyuk Vladislav A VA   Shukla Anil K AK   Monroe Matthew E ME   Gritsenko Marina A MA   Rodland Karin D KD   Smith Richard D RD   Qian Wei-Jun WJ   Gong Cheng-Xin CX   Liu Tao T  

The Journal of pathology 20170728 1


Protein modification by O-linked β-N-acetylglucosamine (O-GlcNAc) is emerging as an important factor in the pathogenesis of sporadic Alzheimer's disease (AD); however, detailed molecular characterization of this important protein post-translational modification at the proteome level has been highly challenging, owing to its low stoichiometry and labile nature. Herein, we report the most comprehensive, quantitative proteomics analysis for protein O-GlcNAcylation in postmortem human brain tissues  ...[more]

Similar Datasets

2024-03-22 | GSE169347 | GEO
| PRJNA716307 | ENA
2017-10-31 | PXD004433 | Pride
2018-10-19 | PXD009029 | Pride
2018-10-22 | PXD008595 | Pride
2019-01-30 | PXD009682 | Pride
2018-10-22 | PXD005055 | Pride
2018-11-21 | PXD008895 | Pride
2017-11-21 | PXD005306 | Pride
2017-05-02 | PXD006066 | Pride